Paclitaxel and Erlotinib-co-loaded Solid Lipid Core Nanocapsules: Assessment of Physicochemical Characteristics and Cytotoxicity in Non-small Cell Lung Cancer

Paclitaxel and Erlotinib-co-loaded Solid Lipid Core Nanocapsules: Assessment of Physicochemical... Pharm Res https://doi.org/10.1007/s11095-017-2337-6 RESEARCH PAPER Paclitaxel and Erlotinib-co-loaded Solid Lipid Core Nanocapsules: Assessment of Physicochemical Characteristics and Cytotoxicity in Non-small Cell Lung Cancer 1 1 1 1 1 1 1 Biki Gupta & Bijay Kumar Poudel & Shobha Regmi & Shiva Pathak & Hima Bindu Ruttala & Milan Gautam & Gyeong Jin An & 1 2 1 1 Jee-Heon Jeong & Han-Gon Choi & Chul Soon Yong & Jong Oh Kim Received: 20 September 2017 /Accepted: 20 December 2017 # Springer Science+Business Media, LLC, part of Springer Nature 2018 ABSTRACT the free drug cocktail. Moreover, well-defined early and late Purpose Lung cancer is the leading cause of cancer-related apoptosis were observed with clearly visible signs of apoptotic deaths. The aim of this study was to design solid lipid core nuclei. nanocapsules (SLCN) comprising a solid lipid core and a Conclusion PTX/ERL-SLCN could be employed as an op- PEGylated polymeric corona for paclitaxel (PTX) and erloti- timal approach for combination chemotherapy of NSCLC. nib (ERL) co-delivery to non-small cell lung cancer (NSCLC), . . and evaluate their physicochemical characteristics and in vitro KEY WORDS Erlotinib paclitaxel solid lipid core activity in NCI-H23 cells. nanocapsules non-smallcelllungcancer Methods PTX/ERL-SLCN were prepared by http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pharmaceutical Research Springer Journals

Paclitaxel and Erlotinib-co-loaded Solid Lipid Core Nanocapsules: Assessment of Physicochemical Characteristics and Cytotoxicity in Non-small Cell Lung Cancer

Loading next page...
 
/lp/springer_journal/paclitaxel-and-erlotinib-co-loaded-solid-lipid-core-nanocapsules-Cy976YfFPx
Publisher
Springer US
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Biomedicine; Pharmacology/Toxicology; Pharmacy; Biochemistry, general; Medical Law; Biomedical Engineering
ISSN
0724-8741
eISSN
1573-904X
D.O.I.
10.1007/s11095-017-2337-6
Publisher site
See Article on Publisher Site

Abstract

Pharm Res https://doi.org/10.1007/s11095-017-2337-6 RESEARCH PAPER Paclitaxel and Erlotinib-co-loaded Solid Lipid Core Nanocapsules: Assessment of Physicochemical Characteristics and Cytotoxicity in Non-small Cell Lung Cancer 1 1 1 1 1 1 1 Biki Gupta & Bijay Kumar Poudel & Shobha Regmi & Shiva Pathak & Hima Bindu Ruttala & Milan Gautam & Gyeong Jin An & 1 2 1 1 Jee-Heon Jeong & Han-Gon Choi & Chul Soon Yong & Jong Oh Kim Received: 20 September 2017 /Accepted: 20 December 2017 # Springer Science+Business Media, LLC, part of Springer Nature 2018 ABSTRACT the free drug cocktail. Moreover, well-defined early and late Purpose Lung cancer is the leading cause of cancer-related apoptosis were observed with clearly visible signs of apoptotic deaths. The aim of this study was to design solid lipid core nuclei. nanocapsules (SLCN) comprising a solid lipid core and a Conclusion PTX/ERL-SLCN could be employed as an op- PEGylated polymeric corona for paclitaxel (PTX) and erloti- timal approach for combination chemotherapy of NSCLC. nib (ERL) co-delivery to non-small cell lung cancer (NSCLC), . . and evaluate their physicochemical characteristics and in vitro KEY WORDS Erlotinib paclitaxel solid lipid core activity in NCI-H23 cells. nanocapsules non-smallcelllungcancer Methods PTX/ERL-SLCN were prepared by

Journal

Pharmaceutical ResearchSpringer Journals

Published: Mar 13, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial